| Literature DB >> 26546047 |
Alyssa L Smith1, Najmeh Alirezaie2, Ashton Connor3, Michelle Chan-Seng-Yue4, Robert Grant5, Iris Selander5, Claire Bascuñana1, Ayelet Borgida6, Anita Hall1, Thomas Whelan5, Spring Holter6, Treasa McPherson5, Sean Cleary6, Gloria M Petersen7, Atilla Omeroglu8, Emmanouil Saloustros9, John McPherson4, Lincoln D Stein4, William D Foulkes10, Jacek Majewski2, Steven Gallinger11, George Zogopoulos12.
Abstract
The genetic basis underlying the majority of hereditary pancreatic adenocarcinoma (PC) is unknown. Since DNA repair genes are widely implicated in gastrointestinal malignancies, including PC, we hypothesized that there are novel DNA repair PC susceptibility genes. As germline DNA repair gene mutations may lead to PC subtypes with selective therapeutic responses, we also hypothesized that there is an overall survival (OS) difference in mutation carriers versus non-carriers. We therefore interrogated the germline exomes of 109 high-risk PC cases for rare protein-truncating variants (PTVs) in 513 putative DNA repair genes. We identified PTVs in 41 novel genes among 36 kindred. Additional genetic evidence for causality was obtained for 17 genes, with FAN1, NEK1 and RHNO1 emerging as the strongest candidates. An OS difference was observed for carriers versus non-carriers of PTVs with early stage (≤IIB) disease. This adverse survival trend in carriers with early stage disease was also observed in an independent series of 130 PC cases. We identified candidate DNA repair PC susceptibility genes and suggest that carriers of a germline PTV in a DNA repair gene with early stage disease have worse survival.Entities:
Keywords: DNA repair genes; Exome sequencing; Familial pancreatic cancer; Pancreatic adenocarcinoma
Mesh:
Substances:
Year: 2015 PMID: 26546047 PMCID: PMC5725760 DOI: 10.1016/j.canlet.2015.10.030
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679